BTBT (22) RM (61) TREE (50) BRBI (46) ⌘ Pro Terminal →

Crescent Capital BDC Inc. (CCAP) — RQD Stock Rating Cockpit

$9.27 -0.32% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.25

Crescent Capital BDC Inc. (CCAP) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $342.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CCAP Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CCAP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Crescent Capital BDC Inc. (NASDAQ: CCAP) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $9.27 (-0.32% 1D, market cap $342.7M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, CCAP ranks #607 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CCAP compare to BTBT and RM in the Financials sector?

▼

Within the Financials sector (Finance: Consumer Services), CCAP carries a Roarable D+ (53/100 RQD), trailing P/E of 9.9x, gross margin of —, and ROIC of -11.1%. By comparison, BTBT (Bit Digital Inc.) holds a E grade (22/100 RQD, P/E N/A, ROIC -12.0%, cap $336.5M) and RM (Regional Management Corp.) posts a C- grade (61/100 RQD, P/E 7.5x, ROIC 11.9%, cap $334.5M). Among the 5-stock peer group, RM leads on earnings multiple (7.5x) while RM leads on capital efficiency (11.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CCAP?

▼

Per CCAP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001633336), Crescent Capital BDC Inc. generated $0 in revenue, $34.5M in net income, and $74.7M in free cash flow against $1.62B in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.25 (-0.25%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 1.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY • 50.6% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-2.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CCAP)Realized 20D OHLCV Swing Band: ±5.2%

Deterministic 5-Pillar Attribution (53/100 Composite)

🔍 WHY CCAP SCORES 53/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+14/20 pts (26% of score)

SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-1.80% YoY Shares)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning7/20 pts (-13 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-13 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$9.14-4.8% Next Q

Q2 (-2Q)

Grade D$8.70+0% Next Q

Q3 (-1Q)

Grade C-$8.70+6.6% Next Q

Current

Grade D+$9.27-0.9% Hist 90D α

Trajectory: D (45) → D+ (53)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CCAP Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CCAP currently carries a cautious 53/100 (D+) rating due to Whale & Options Positioning (7/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.57) and Max Pain ($9.73) forces dealer call-delta covering toward $15.94.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CCAP• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CCAP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 53%NO 47%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

54.430 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

4 / 99-Pt Accounting

52-WEEK LASER RANGE13% OF RANGE

L: $8$9.27H: $15

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: D+RQD 11 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D+RQD 21 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D+RQD 21 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on CCAP

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (55)

-11.1% ROIC with 42.0% gross margin and 21.81% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (65)

Altman-Z 4.20 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (48)

21/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like CCAP

✓Company leadership has skin in the game with net positive insider conviction.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CCAP)

✓Walkthrough of CCAP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CCAP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -33.31%📐 HORIZONTAL RANGE

2026-11-02O $9.01H $9.30L $9.01C $9.27VOL 172.2K

RES: $12.25SUP: $8.12SMA50: $9.57SMA200: $11.68

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CCAP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CCAP Butterfly Map → + Track CCAP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-1.4%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CCAP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CCAP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CCAP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CCAP)

Financials Rank #607 of 1096 ⚔️ BTBT vs CCAP Full Matrix →

1. Head-to-Head Financials Peer Comparison (CCAP vs. BTBT, RM, TREE, BRBI)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Crescent Capital BDC Inc. (CCAP) ranks #607 by composite RQD confidence (53/100, grade D+) and #784 by equity capitalization ($342.7M). Within this direct 5-issuer industry benchmark cohort, RM leads on earnings valuation at 7.5x trailing P/E, while RM leads on capital efficiency and profitability with 11.9% ROIC and — gross margin. RM currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with CCAP at 53/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CCAP ACTIVE Crescent Capital BDC Inc.	D+	53/100	9.9x	—	-11.1%	-0.32%	$342.7M	Benchmark Subject
BTBT Bit Digital Inc.	E	22/100	—	—	-12.0%	-14.27%	$336.5M	/btbt-vs-ccap →
RM Regional Management Corp.	C-	61/100	7.5x	—	11.9%	+0.11%	$334.5M	/rm-vs-ccap →
TREE LendingTree Inc.	D	50/100	—	—	8.6%	-0.32%	$393.5M	/tree-vs-ccap →
BRBI BRBI BR Partners S.A. ADSs	D	46/100	—	—	—	-11.65%	$400.1M	/brbi-vs-ccap →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001633336

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Crescent Capital BDC Inc. (CCAP) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $34.5M, operating cash flow of $74.7M, and free cash flow of $74.7M (+26.8% YoY). On the balance sheet, CCAP closed FY2025 with $1.62B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	$34.5M	$74.7M	$74.7M	$1.62B	—
FY2024 (FY)	2024-12-31	$0	$73.6M	$58.9M	$58.9M	$1.66B	—
FY2023 (FY)	2023-12-31	$0	$83.8M	$92.3M	$92.3M	—	—

3. CCAP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CCAP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CCAP compare to BTBT and RM in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for CCAP?

Where is CCAP trading relative to its 50-day, 200-day, and 52-week technical levels?

CCAP last traded at $9.27 (-0.32% on volume of 233,473 shares), positioning the stock -3.13% below its 50-day simple moving average ($9.57) and -20.63% below its 200-day simple moving average ($11.68). Across its 52-week range of $8.40 to $15.18, CCAP sits at the 12.8% percentile with a 14-day RSI of 54.4 (NEUTRAL RANGE) and an implied next-earnings move of ±5.2% ($8.79 to $9.75).

CCAP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell CCAP stock right now?

Crescent Capital BDC Inc. (CCAP) currently earns a Roarable Rating of D+ (Sell — SELL) with 53/100 RQD Confidence. Stretched risk/reward at 10x P/E (-11% return on capital) under elevated 10-year interest-rate pressure.

What is CCAP's 12-month price target and RQD AI Jury consensus?

CCAP's 12-month base price target is $9.06 (range $7.07 to $15.94), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: CCAP RQD Cockpit CCAP 12M Forecast CCAP Earnings & Move CCAP Dividends & DRIP CCAP Insiders & 13F CCAP Whale Options CCAP Profit Sankey CCAP News & Why